Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-039654

President, R&D sold 8,999 shares at an average $20.03 ($180,290)

  • President, R&D acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bergstrom Donald A President, R&D 2022-06-24 Option exercise +8,000 $4.12 $32,960 100,493 D: show line 1 in the form
Bergstrom Donald A President, R&D 2022-06-24 Sale −8,000 $20.00 $160,000 92,493 D: show line 2 in the form
Bergstrom Donald A President, R&D 2022-06-27 Sale −999 $20.31 $20,290 91,494 D: show line 3 in the form
Open-market sales · 8,999 sh · avg $20.03 · $180,290

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bergstrom Donald A President, R&D 2022-06-24 Option exercise · Stock Option (Right to Buy) −8,000 178,456 D: show line 4 in the form
Loading xslF345X03/doc4.xml…